Condition: Hypertension · Vascular Diseases · Cardiovascular Diseases · Sponsor: Medtronic Vascular
The purpose of this single-arm interventional study is to evaluate the long-term safety, efficacy, and durability of the Symplicity Spyral system in subjects treated with renal denervation. Additionally, long-term follow-up data will also be collected from eligible subjects previously treated in the SPYRAL PIVOTAL-SPYRAL HTN-OFF MED and SPYRAL HTN-ON MED studies.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham (UAB) Hospital | Birmingham, Alabama, United States | — |
| Banner Heart Hospital | Mesa, Arizona, United States | — |
| Abrazo Arizona Heart Hospital/Biltmore Cardiology | Phoenix, Arizona, United States | — |
| HonorHealth Research Institute | Scottsdale, Arizona, United States | — |
| Arkansas Cardiology | Little Rock, Arkansas, United States | — |
| Scripps Memorial Hospital | La Jolla, California, United States | — |
| University of California, San Francisco | San Francisco, California, United States | — |
| Stanford Hospital and Clinics | Stanford, California, United States | — |
| University of Colorado Anschutz Medical Campus | Aurora, Colorado, United States | — |
| Colorado Heart and Vascular PC | Lakewood, Colorado, United States | — |
| Hartford Hospital | Hartford, Connecticut, United States | — |
| MedStar Washington Hospital Center | Washington D.C., District of Columbia, United States | — |
+ 87 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.